Stocksigma LogoStocksigma Logo

Sanofi India Reports Robust Q3'26 Profit Growth and Declares ₹75 Interim Dividend

Sanofi India posted a 3.4% YoY rise in Q3'26 revenue from operations to ₹4,917 million, while net profit surged 53.6% YoY to ₹1,167 million, driven by

Sanofi India Reports Robust Q3'26 Profit Growth and Declares ₹75 Interim Dividend

Sanofi India Ltd · Dividend · 30 Oct 2026, 12:13 am

Sanofi India Reports Robust Q3'26 Profit Growth and Declares ₹75 Interim Dividend Sanofi India posted a 3.4% YoY rise in Q3'26 revenue from operations to ₹4,917 million, while net profit surged 53.6% YoY to ₹1,167 million, driven by gross margin expansion, favorable product mix, and an 8% drop in operating expenses. Profit before tax rose 22% YoY to ₹1,577 million. Performance was supported by 9% growth in the insulin portfolio (55% market share) and an 85% surge in public sector business. The board declared an interim dividend of ₹75 per share with a record date of 5th Nov'26.

Original exchange filing (PDF)

More announcements from Sanofi India Ltd

All Sanofi India Ltd announcements